iRhythm Technologies Inc (IRTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has a cash flow conversion efficiency ratio of -0.162x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.17 Million) by net assets ($161.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IRTC market cap for the company's overall valuation and market capitalisation.
iRhythm Technologies Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
iRhythm Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iRhythm Technologies Inc ranked by their cash flow conversion efficiency. Explore IRTC cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FIT Hon Teng Limited
F:0FJ
|
0.040x |
|
PTC INDUSTRIES LTD
NSE:PTCIL
|
-0.027x |
|
WSFS Financial Corporation
NASDAQ:WSFS
|
0.045x |
|
Fosun International Limited
F:FNI
|
0.045x |
|
Granite Real Estate Investment Trust
TO:GRT-UN
|
0.017x |
|
Ideaya Biosciences Inc
NASDAQ:IDYA
|
-0.136x |
|
Monday.Com Ltd
NASDAQ:MNDY
|
0.138x |
|
Charoen Pokphand Foods Public Company Limited
F:NVAV
|
0.042x |
Annual Cash Flow Conversion Efficiency for iRhythm Technologies Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. View IRTC stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $152.75 Million | $80.86 Million | 0.529x | +1319.65% |
| 2024-12-31 | $90.91 Million | $3.39 Million | 0.037x | +115.64% |
| 2023-12-31 | $210.10 Million | $-50.10 Million | -0.238x | -148.51% |
| 2022-12-31 | $239.81 Million | $-23.01 Million | -0.096x | +28.95% |
| 2021-12-31 | $279.51 Million | $-37.75 Million | -0.135x | -235.35% |
| 2020-12-31 | $341.61 Million | $-13.76 Million | -0.040x | +75.05% |
| 2019-12-31 | $135.41 Million | $-21.86 Million | -0.161x | +69.77% |
| 2018-12-31 | $54.42 Million | $-29.07 Million | -0.534x | -184.96% |
| 2017-12-31 | $79.55 Million | $-14.91 Million | -0.187x | -4.19% |
| 2016-12-31 | $92.56 Million | $-16.65 Million | -0.180x | -201.53% |
| 2015-12-31 | $-101.62 Million | $-18.00 Million | 0.177x | +108.24% |
| 2014-12-31 | $7.26 Million | $-15.63 Million | -2.151x | +16.49% |
| 2013-12-31 | $4.60 Million | $-11.85 Million | -2.576x | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more